Clinical trial for autologous bone marrow stem cells as treatment for AMD & RP shows promise

A phase 1 clinical trial utilizing human bone marrow CD34+ stem cells for patients with retinal vascular occlusion, hereditary or non-exudative age-related macular degeneration (AMD), or retinitis pigmentosa (RP) has shown safety and feasibility.

Read more…

Posted in Age-related Macular Degeneration, Retinitis Pigmentosa, Stargardt's disease, Stem Cells.

Leave a Reply